News | January 08, 2025
Ajooni Biotech to raise Rs. 45 crore through convertible warrants
These initiatives will strengthen the company’s capital base, providing financial flexibility for future
These initiatives will strengthen the company’s capital base, providing financial flexibility for future
The first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
Lupin can receive a potential total consideration of up to USD 84 million based on future contingent milestones
Felzartamab demonstrated positive interim results from the Phase 2 IgA nephropathy (IgAN) study
Acquisition will advance Merck’s integrated offering for viral vector manufacturing
1,000 Ph.D. students will be enrolled in the next five years to drive innovation in the critical healthcare sector
This Phase III clinical trial is a randomized, double-blind, placebo-controlled, multicenter clinical trial in China to evaluate the safety and efficacy of ASC40
Five batches across four programs of Biocon Academy participated in the graduation ceremony
Investment is additive to KKR’s existing health care growth strategy
Subscribe To Our Newsletter & Stay Updated
